Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 4/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | RXRA | P19793 | 2/20 | 0.32 |
| ▸ | RXRG | P48443 | 1/20 | 0.32 |
| ▸ | XDH | P47989 | 2/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21440706 | 0.97 | AR (0.36) | ARCYP11B1CYP11B2RXRARXRG | |
| SCHEMBL19912439 | 0.95 | AR (0.36) | ARCYP11B1CYP11B2XDHPGR | |
| SCHEMBL19913252 | 0.94 | METAP2 (0.34) | ARCYP11B1CYP11B2XDHCTSS | |
| SCHEMBL22822333 | 0.94 | RXRA (0.38) | ARCYP11B1CYP11B2RXRARXRG | |
| SCHEMBL19912417 | 0.94 | AR (0.39) | ARRXRARXRGXDHSMN1; SMN2 | |
| SCHEMBL19918042 | 0.93 | AR (0.36) | ARCYP11B1CYP11B2RXRAXDH | |
| SCHEMBL19912409 | 0.92 | AR (0.35) | ARTSHRSMN1; SMN2CTSSCTSK | |
| SCHEMBL19917927 | 0.92 | CYP11B1 (0.36) | ARCYP11B1CYP11B2RXRARXRG | |
| SCHEMBL19913115 | 0.92 | CYP11B1 (0.34) | ARCYP11B1CYP11B2XDHTSHR | |
| SCHEMBL19912421 | 0.92 | AR (0.38) | ARRXRARXRGXDHSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | AR 4212/4885CYP11B1 823/4885CYP11B2 550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.